02
By The Numbers*
50+
Our technology is backed by over 50 patents, protecting and advancing exclusive imaging and endoscopic capabilities.
Patents For Advancing Imaging and Endoscopic Capabilities
10x
Our single-use design is crafted with the goal of reducing cross-contamination risks by up to 10 times the current rate, supporting safer procedures for patients.
We Aim To Reduce Cross-Contamination Risks
30%
Our technology is developed to help streamline complex procedures, with the potential to reduce operating time and improve patient throughput.
Possible Reduction In Procedure Time With Improved Efficiency
1
Our endoscope is designed to contribute to cost efficiency, with the possibility of just one additional procedure offering measurable ROI.
Procedure Aims To Cover The Entire Unit Investment
99.99%
Our device aims to achieve illumination efficiency far beyond standard CMOS cameras, working to provide clear and precise imaging for diagnostics.
Illumination Efficiency Potential vs. Traditonal CMOS Solutions
40%
Our advanced imaging technology aspires to support higher success rates with the goal of improving patient outcomes.
Aiming For Higher Success Rates In Complex Cases
* Source: JACC: Cardiovascular Interventions. "Chronic Total Occlusion Percutaneous Coronary Interventions: Evidence, Techniques, and Outcomes." Accessed at https://www.jacc.org/doi/full/10.1016/j.jcin.2009.02.008.
SPEAKER:
DATE:
February 9, 2026
TIME:
Feb 9 - 12, 2026
LOCATION:
Dubai Exhibition Centre, UAE
VerAvanti is developing next-generation intravascular imaging technology designed to enable direct, real-time visualization inside coronary arteries during intervention.
Visit us at WHX Dubai 2026 to learn how Scanning Fiber Endoscope (SFE) technology may redefine intravascular imaging and procedural guidance.
Event Details
Date: February 9–12, 2026
Location: South Hall 11, Dubai Exhibition Centre, UAE
Booth: D73
Intended Clinical Value
VerAvanti's Scanning Fiber Endoscope is being developed to support:
Direct visualization of plaque and vessel surfaces
Assessment of lesion morphology
Visualization of dissections and vessel injury
Evaluation of stent–vessel interaction
Real-time intravascular guidance during PCI
What You’ll See at Our Booth
Live technology demonstrations
Overview of system design and imaging principles
Intended clinical workflow and use cases
Discussion of development roadmap
Who Should Visit
Interventional cardiologists
Cath lab directors and managers
Clinical researchers
Distributors and strategic partners
Investors in cardiovascular technology
We look forward to connecting and sharing more about VerAvanti’s technology at WHX Dubai 2026!